ELIEM THERAPEUTICS INC (ELYM) Institutional Ownership

ELYM is currently held by 1 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $1.49M based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026.

The largest disclosed holder is Renaissance Technologies LLC, which reported ownership valued at approximately $1.49M in its March 31, 2026 13F filing.

Major shareholders tracked on this page include Renaissance Technologies LLC, and other prominent asset managers. Collectively, these investors account for approximately 100% of the total disclosed value among the investors covered in this analysis.

This page tracks institutional holding trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance to help investors analyze smart money sentiment toward ELIEM THERAPEUTICS INC (ELYM).

Institutional Ownership Trend

Portfolio quarterInstitutional holdersTotal reported valueTotal shares
Q1 20261$1,488,505217,300
Q4 20251$1,282,400320,600
Q3 20251$1,079,571537,100
Q2 20251$614,420495,500
Q1 20251$627,566514,398
Q4 20241$670,140372,300
Q3 20241$349,17468,600
Q2 20241$263,07037,000
Q1 20241$2910,617
Q4 20231$2910,603